News

Sixth disclosure of collaborations under Sunshine Act legal framework

A total of 693 pharmaceutical and medical technology companies submitted their data related to the year 2022. Together, they invested a total of €268.768.800 in 2022 in collaborations with healthcare providers, healthcare institutions and patient associations active in Belgium.

For the press release and more results, click (NL or FR).

2023-06-28T08:01:56+00:0028 June 2023|

Mdeon once again recognized to manage the transparency platform provided by the Sunshine Act

The Belgian Official Journal published today the Royal Decree of 8 June 2021 which designates once again the non-profit association Mdeon to carry out the missions entrusted to the FAMHP by the Sunshine Act. In particular, Mdeon manages the unique publicly accessible website (www.betransparent.be) which discloses annually the premiums and benefits that pharmaceutical and medical devices companies grant to healthcare professionals/organisations and patient organizations.

The authorization granted to Mdeon is valid for a period of 4 years (1.1.2022 – 31.12.2026).

2021-07-29T09:08:40+00:0029 July 2021|

Companies, healthcare providers, healthcare institutions and patient associations are once again fully opting for transparency – 4th publication of collaborations under the legal framework of the Sunshine Act

A total of 643 pharmaceutical and medical technology companies submitted their data for the year 2020. Together in 2020, they invested a total of 191.397.504 euros in collaborations with healthcare providers, healthcare institutions and patient associations active in Belgium.

For more results and the press release, click here (in Dutch) or here (in French).

2021-06-28T07:07:38+00:0028 June 2021|
Go to Top